#BEGIN_DRUGCARD DB03413

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C9H14N2O11P2

# Chemical_IUPAC_Name:
[({[(2S,3R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Deoxyuridine-5'-Diphosphate

# HET_ID:
DUD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H14N2O11P2/c12-5-3-8(11-2-1-7(13)10-9(11)14)21-6(5)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,10,13,14)(H2,15,16,17)/t5-,6+,8-/m1/s1

# InChI_Key:
InChIKey=QHWZTVCCBMIIKE-GKROBHDKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3413

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
388.1618

# Molecular_Weight_Mono:
388.007282324

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1OGK

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.99

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
8.03e+00 g/l

# Primary_Accession_No:
DB03413

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936665

# PubChem_Substance_ID:
46508146

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01297

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@@H]1C[C@@H](O[C@H]1CO[P@](O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:13 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Isoform DUT-N:Nucleus. Isoform DUT-M:Mitochondrion

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
DUT

# Drug_Target_1_GenBank_ID_Gene:
AF018432

# Drug_Target_1_GenBank_ID_Protein:
2443580

# Drug_Target_1_GeneCard_ID:
DUT

# Drug_Target_1_Gene_Name:
DUT

# Drug_Target_1_Gene_Sequence:
>759 bp
ATGACTCCCCTCTGCCCTCGCCCCGCGCTCTGCTACCATTTCCTTACGTCTCTGCTTCGC
TCAGCGATGCAAAACGCGCGAGGCACGGCAGAGGGCCGAAGCCGCGGTACTCTCCGGGCC
AGGCCCGCCCCTCGGCCGCCGGCCGCGCAGCACGGGATTCCCCGGCCGCTGTCCAGCGCT
GGCCGCCTGAGCCAAGGCTGCCGCGGAGCCAGTACAGTCGGGGCCGCTGGCTGGAAGGGC
GAGCTTCCTAAGGCGGGGGGAAGCCCGGCGCCGGGGCCGGAGACACCCGCCATTTCACCC
AGTAAGCGGGCCCGGCCTGCGGAGGTGGGCGGCATGCAGCTCCGCTTTGCCCGGCTCTCC
GAGCACGCCACGGCCCCCACCCGGGGCTCCGCGCGCGCCGCGGGCTACGACCTGTACAGT
GCCTATGATTACACAATACCACCTATGGAGAAAGCTGTTGTGAAAACGGACATTCAGATA
GCGCTCCCTTCTGGGTGTTATGGAAGAGTGGCTCCACGGTCAGGCTTGGCTGCAAAACAC
TTTATTGATGTAGGAGCTGGTGTCATAGATGAAGATTATAGAGGAAATGTTGGTGTTGTA
CTGTTTAATTTTGGCAAAGAAAAGTTTGAAGTCAAAAAAGGTGATCGAATTGCACAGCTC
ATTTGCGAACGGATTTTTTATCCAGAAATAGAAGAAGTTCAAGCCTTGGATGACACCGAA
AGGGGTTCAGGAGGTTTTGGTTCCACTGGAAAGAATTAA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
1325640	McIntosh EM, Ager DD, Gadsden MH, Haynes RH: Human dUTP pyrophosphatase: cDNA sequence and potential biological importance of the enzyme. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8020-4.
8389461	Strahler JR, Zhu XX, Hora N, Wang YK, Andrews PC, Roseman NA, Neel JV, Turka L, Hanash SM: Maturation stage and proliferation-dependent expression of dUTPase in human T cells. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4991-5.
8631816	Ladner RD, McNulty DE, Carr SA, Roberts GD, Caradonna SJ: Characterization of distinct nuclear and mitochondrial forms of human deoxyuridine triphosphate nucleotidohydrolase. J Biol Chem. 1996 Mar 29;271(13):7745-51.

# Drug_Target_1_HGNC_ID:
HGNC:3078

# Drug_Target_1_HPRD_ID:
03165

# Drug_Target_1_ID:
2223

# Drug_Target_1_Locus:
15q15-q21.1

# Drug_Target_1_Molecular_Weight:
26707

# Drug_Target_1_Name:
Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial

# Drug_Target_1_Number_of_Residues:
252

# Drug_Target_1_PDB_ID:
1Q5U

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00692	dUTPase

# Drug_Target_1_Protein_Sequence:
>Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor
MTPLCPRPALCYHFLTSLLRSAMQNARGTAEGRSRGTLRARPAPRPPAAQHGIPRPLSSA
GRLSQGCRGASTVGAAGWKGELPKAGGSPAPGPETPAISPSKRARPAEVGGMQLRFARLS
EHATAPTRGSARAAGYDLYSAYDYTIPPMEKAVVKTDIQIALPSGCYGRVAPRSGLAAKH
FIDVGAGVIDEDYRGNVGVVLFNFGKEKFEVKKGDRIAQLICERIFYPEIEEVQALDDTE
RGSGGFGSTGKN

# Drug_Target_1_Reaction:
dUTP + H2O = dUMP + diphosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
This enzyme is involved in nucleotide metabolism:it produces dUMP, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dUTP so that uracil cannot be incorporated into DNA

# Drug_Target_1_SwissProt_ID:
P33316

# Drug_Target_1_SwissProt_Name:
DUT_HUMAN

# Drug_Target_1_Synonyms:
Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor
EC 3.6.1.23
dUTP pyrophosphatase
dUTPase

# Drug_Target_1_Theoretical_pI:
10.01

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X01714

# Drug_Target_2_GenBank_ID_Protein:
41297

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
dut

# Drug_Target_2_Gene_Sequence:
>456 bp
ATGAAAAAAATCGACGTTAAGATTCTGGACCCGCGCGTTGGGAAGGAATTTCCGCTCCCG
ACTTATGCCACCTCTGGCTCTGCCGGACTTGACCTGCGTGCCTGTCTCAACGACGCCGTA
GAACTGGCTCCGGGTGACACTACGCTGGTTCCGACCGGGCTGGCGATTCATATTGCCGAT
CCTTCACTGGCGGCAATGATGCTGCCGCGCTCCGGATTGGGACATAAGCACGGTATCGTG
CTTGGTAACCTGGTAGGATTGATCGATTCTGACTATCAGGGCCAGTTGATGATTTCCGTG
TGGAACCGTGGTCAGGACAGCTTCACCATTCAACCTGGCGAACGCATCGCCCAGATGATT
TTTGTTCCGGTAGTACAGGCTGAATTTAATCTGGTGGAAGATTTCGACGCCACCGACCGC
GGTGAAGGCGGCTTTGGTCACTCTGGTCGTCAGTAA

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
11375495	Gonzalez A, Larsson G, Persson R, Cedergren-Zeppezauer E: Atomic resolution structure of Escherichia coli dUTPase determined ab initio. Acta Crystallogr D Biol Crystallogr. 2001 Jun;57(Pt 6):767-74. Epub 2001 May 25.
1311056	Cedergren-Zeppezauer ES, Larsson G, Nyman PO, Dauter Z, Wilson KS: Crystal structure of a dUTPase. Nature. 1992 Feb 20;355(6362):740-3.
6139280	Lundberg LG, Thoresson HO, Karlstrom OH, Nyman PO: Nucleotide sequence of the structural gene for dUTPase of Escherichia coli K-12. EMBO J. 1983;2(6):967-71.
7686882	Burland V, Plunkett G 3rd, Daniels DL, Blattner FR: DNA sequence and analysis of 136 kilobases of the Escherichia coli genome: organizational symmetry around the origin of replication. Genomics. 1993 Jun;16(3):551-61.
8646539	Larsson G, Svensson LA, Nyman PO: Crystal structure of the Escherichia coli dUTPase in complex with a substrate analogue (dUDP). Nat Struct Biol. 1996 Jun;3(6):532-8.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9757088	Dauter Z, Wilson KS, Larsson G, Nyman PO, Cedergren-Zeppezauer ES: The refined structure of dUTPase from Escherichia coli. Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):735-49.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2490

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
16156

# Drug_Target_2_Name:
Deoxyuridine 5'-triphosphate nucleotidohydrolase

# Drug_Target_2_Number_of_Residues:
151

# Drug_Target_2_PDB_ID:
1EUW

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00692	dUTPase

# Drug_Target_2_Protein_Sequence:
>Deoxyuridine 5'-triphosphate nucleotidohydrolase
MKKIDVKILDPRVGKEFPLPTYATSGSAGLDLRACLNDAVELAPGDTTLVPTGLAIHIAD
PSLAAMMLPRSGLGHKHGIVLGNLVGLIDSDYQGQLMISVWNRGQDSFTIQPGERIAQMI
FVPVVQAEFNLVEDFDATDRGEGGFGHSGRQ

# Drug_Target_2_Reaction:
dUTP + H2O = dUMP + diphosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
This enzyme is involved in nucleotide metabolism:it produces dUMP, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dUTP so that uracil cannot be incorporated into DNA

# Drug_Target_2_SwissProt_ID:
P06968

# Drug_Target_2_SwissProt_Name:
DUT_ECOLI

# Drug_Target_2_Synonyms:
EC 3.6.1.23
dUTP pyrophosphatase
dUTPase

# Drug_Target_2_Theoretical_pI:
4.87

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
BX842580

# Drug_Target_3_GenBank_ID_Protein:
2181988

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
dut

# Drug_Target_3_Gene_Sequence:
>465 bp
TCACAAACTCGCATGTCCGCCGGAGGAACCGTGGCCACCGTCGCCGCGGGATGTCGAGGC
CAGCCCGGCCTCGTCGAACGACGAGACCTCGACCAGCTCGACCAACTCAACCCGTTGCAC
TAGCAACTGGGCGATTCGGTCACCGCGATGTACCACGATGGGCGCGGCTGGGTCCAAGTT
GATCAGGGCCACCTTGATCTCCCCACGATAACCCGCGTCGATGGTGCCCGGACTGTTGAC
GATCGAAAGCCCCACCCGCGTGGCCAACCCGGAGCGCGGATGGACCAGCCCGACCATGCC
GAACGGGACGGCGACCGCAACACCCGTCCGTACCAGGGCGCGGCGCCCAGGTGCCAGCTC
GACGTCTTCGGCGCTGTAGAGATCAACGCCGGCGTCGCCGTCGTGAGCGCGGCTGGGCAG
CGGGAGCCCGGGGTCGAGGCGGACGATCGCCAGAGTGGTCGACAC

# Drug_Target_3_General_Function:
Nucleotide transport and metabolism

# Drug_Target_3_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2410

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
15803

# Drug_Target_3_Name:
Deoxyuridine 5'-triphosphate nucleotidohydrolase

# Drug_Target_3_Number_of_Residues:
154

# Drug_Target_3_PDB_ID:
1MQ7

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00692	dUTPase

# Drug_Target_3_Protein_Sequence:
>Deoxyuridine 5'-triphosphate nucleotidohydrolase
MSTTLAIVRLDPGLPLPSRAHDGDAGVDLYSAEDVELAPGRRALVRTGVAVAVPFGMVGL
VHPRSGLATRVGLSIVNSPGTIDAGYRGEIKVALINLDPAAPIVVHRGDRIAQLLVQRVE
LVELVEVSSFDEAGLASTSRGDGGHGSSGGHASL

# Drug_Target_3_Reaction:
dUTP + H2O = dUMP + diphosphate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
This enzyme is involved in nucleotide metabolism:it produces dUMP, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dUTP so that uracil cannot be incorporated into DNA

# Drug_Target_3_SwissProt_ID:
P0A552

# Drug_Target_3_SwissProt_Name:
DUT_MYCTU

# Drug_Target_3_Synonyms:
EC 3.6.1.23
dUTP pyrophosphatase
dUTPase

# Drug_Target_3_Theoretical_pI:
5.99

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
U93211

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
Tcdut

# Drug_Target_4_Gene_Sequence:
>852 bp
ATGAATCGCGTGCAAAGTGGCTTCCGTGTGCCCGCCAGGGTCCTGAACTCCCTCGCCCAT
TTGCAGGACGGCCTCAACATCTTTATGGATCCCGACTGGCGTCAGATCCGCCACGTTGAC
GACTGGGCTCTCGCCATCACGATGGAAAGCGCCGAGCTGATTGACTCCTACCCGTGGAAG
TGGTGGAAGAACGTGAAGGCACAGACGGACATGCACAACGTGAGAATTGAGATTGCCGAC
ATTCTGCACTTCTCGCTCTCTGGTGAGATACAGAAGCGCACGCAGGACGAAAAAGGGGCG
GATGATGTCGCCCTGAAGTCGCTGAAAGAAATGGGCTTCTTTTGCCGTCCACCTGCACAC
GCAAAGTCAACGGCAGCTTCCGGCCAAAGGACGAATGGTGGCGATGGCGATGGTGATGAT
GAGTTGTTGGAACTCATGTTTTTTCCGCTTACAGAAGTTGCCAGTGCTGTGGCGACATTT
CGCAACATCATCCAGTTGGCCAGCATATATCGCTTTGACCTCATCACGAAGGGCCTGCTG
TTGGCGGCGCAGGACTTGGACTTTAACCTCGTTGGCTACTACGTGGCCAAATATACACTG
AACCAAATCCGTCAGCTGAAGGGTTACAAGGAGGGCGTGTACGTGAAGGTCCGTGAGGGT
GTTGAGGATAATGAGCTCCTGCACGAGTGCGTCCAATCCGTTTCAGTGGAAGATGTGCTC
AACGAGGGGACGTACCTAAAGGCATGGGAGAAAATCGCCTGCTCCGTATTCGATGCATTT
GGTATGCCCGAGGAGGAAAGGCGGCACGCGTATGATTGGTTGAAATCGGCAGCTTTGGAC
GGGAAGGGGTAG

# Drug_Target_4_General_Function:
Not Available

# Drug_Target_4_General_References:
12208522	Bernier-Villamor V, Camacho A, Hidalgo-Zarco F, Perez J, Ruiz-Perez LM, Gonzalez-Pacanowska D: Characterization of deoxyuridine 5'-triphosphate nucleotidohydrolase from Trypanosoma cruzi. FEBS Lett. 2002 Aug 28;526(1-3):147-50.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
5255

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
32066

# Drug_Target_4_Name:
Deoxyuridine triphosphatase

# Drug_Target_4_Number_of_Residues:
283

# Drug_Target_4_PDB_ID:
1OGL

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
Not Available

# Drug_Target_4_Protein_Sequence:
>Deoxyuridine triphosphatase
MNRVQSGFRVPARVLNSLAHLQDGLNIFMDPDWRQIRHVDDWALAITMESAELIDSYPWK
WWKNVKAQTDMHNVRIEIADILHFSLSGEIQKRTQDEKGADDVALKSLKEMGFFCRPPAH
AKSTAASGQRTNGGDGDGDDELLELMFFPLTEVASAVATFRNIIQLASIYRFDLITKGLL
LAAQDLDFNLVGYYVAKYTLNQIRQLKGYKEGVYVKVREGVEDNELLHECVQSVSVEDVL
NEGTYLKAWEKIACSVFDAFGMPEEERRHAYDWLKSAALDGKG

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
O15923

# Drug_Target_4_SwissProt_Name:
O15923_TRYCR

# Drug_Target_4_Synonyms:
Deoxyuridine triphosphatase, putative
EC 3.6.1.23

# Drug_Target_4_Theoretical_pI:
4.97

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasmic

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
pol

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Involved in hydrolase activity

# Drug_Target_5_General_References:
2431539	Rushlow K, Olsen K, Stiegler G, Payne SL, Montelaro RC, Issel CJ: Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology. 1986 Dec;155(2):309-21.
3003905	Stephens RM, Casey JW, Rice NR: Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus. Science. 1986 Feb 7;231(4738):589-94.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
5256

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
129521

# Drug_Target_5_Name:
Pol polyprotein

# Drug_Target_5_Number_of_Residues:
1145

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00075	RnaseH
PF00077	RVP
PF00078	RVT_1
PF00552	Integrase
PF00665	rve
PF00692	dUTPase
PF02022	Integrase_Zn
PF06815	RVT_connect
PF06817	RVT_thumb

# Drug_Target_5_Protein_Sequence:
>Pol polyprotein
TAWTFLKAMQKCSKKREARGSREAPETNFPDTTEESAQQICCTRDSSDSKSVPRSERNKK
GIQCQGEGSSRGSQPGQFVGVTYNLEKRPTTIVLINDTPLNVLLDTGADTSVLTTAHYNR
LKYRGRKYQGTGIIGVGGNVETFSTPVTIKKKGRHIKTRMLVADIPVTILGRDILQDLGA
KLVLAQLSKEIKFRKIELKEGTMGPKIPQWPLTKEKLEGAKETVQRLLSEGKISEASDNN
PYNSPIFVIKKRSGKWRLLQDLRELNKTVQVGTEISRGLPHPGGLIKCKHMTVLDIGDAY
FTIPLDPEFRPYTAFTIPSINHQEPDKRYVWKCLPQGFVLSPYIYQKTLQEILQPFRERY
PEVQLYQYMDDLFVGSNGSKKQHKELIIELRAILQKGFETPDDKLQEVPPYSWLGYQLCP
ENWKVQKMQLDMVKNPTLNDVQKLMGNITWMSSGVPGLTVKHIAATTKGCLELNQKVIWT
EEAQKELEENNEKIKNAQGLQYYNPEEEMLCEVEITKNYEATYVIKQSQGILWAGKKIMK
ANKGWSTVKNLMLLLQHVATESITRVGKCPTFKVPFTKEQVMWEMQKGWYYSWLPEIVYT
HQVVHDDWRMKLVEEPTSGITIYTDGGKQNGEGIAAYVTSNGRTKQKRLGPVTHQVAERM
AIQMALEDTRDKQVNIVTDSYYCWKNITEGLGLEGPQNPWWPIIQNIREKEIVYFAWVPG
HKGIYGNQLADEAAKIKEEIMLAYQGTQIKEKRDEDAGFDLCVPYDIMIPVSDTKIIPTD
VKIQVPPNSFGWVTGKSSMAKQGLLINGGIIDEGYTGEIQVICTNIGKSNIKLIEGQKFA
QLIILQHHSNSRQPWDENKISQRGDKGFGSTGVFWVENIQEAQDEHENWHTSPKILARNY
KIPLTVAKQITQECPHCTKQGSGPAGCVMRSPNHWQADCTHLDNKIILHFVESNSGYIHA
TLLSKENALCTSLAILEWARLFSPKSLHTDNGTNFVAEPVVNLLKFLKIAHTTGIPYHPE
SQGIVERANRTLKEKIQSHRDNTQTLEAALQLALITCNKGRESMGGQTPWEVFITNQAQV
IHEKLLLQQAQSSKKFCFYKIPGEHDWKGPTRVLWKGDGAVVVNDEGKGIIAVPLTRTKL
LIKPN

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
During replicative cycle of retroviruses, the reverse- transcribed viral DNA is integrated into the host chromosome by the viral integrase enzyme. RNase H activity is associated with the reverse transcriptase

# Drug_Target_5_SwissProt_ID:
P03371

# Drug_Target_5_SwissProt_Name:
POL_EIAVY

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
8.89

# Drug_Target_5_Transmembrane_Regions:
None

#END_DRUGCARD DB03413
